William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Merifund Capital: Insurtech Exzeo Making Market Debut
-
Investors push Argentina for flexible peso amid reserve, FDI concerns
-
William Blair Downgrades Mersana (MRSN) to Market Perform
-
William Blair Downgrades Korro Bio Inc. (KRRO) to Market Perform
-
William Blair on Cisco (CSCO): 'persistent competition across its core networking and security portfolios is likely to challenge Cisco'
-
Form SCHEDULE 13G/A MERCURY SYSTEMS INC Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Montrose Environmental Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A GeneDx Holdings Corp. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G AMICUS THERAPEUTICS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G Perella Weinberg Partner Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G TREACE MEDICAL CONCEPTS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G National Vision Holdings Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Sep 30
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Sep 30
-
William Blair Reiterates Outperform Rating on Circle Internet Group (CRCL)
-
William Blair Reiterates Outperform Rating on Oklo (OKLO)
-
William Blair Downgrades Endava PLC (ADR) (DAVA) to Market Perform
-
William Blair Downgrades TreeHouse Foods (THS) to Market Perform
-
William Blair Reiterates Market Perform Rating on uniQure BV (QURE)
-
William Blair Reiterates Outperform Rating on Yeti Holdings Inc. (YETI)
-
William Blair Reiterates Outperform Rating on PowerFleet, Inc (AIOT)
-
William Blair Reiterates Market Perform Rating on Biohaven Pharmaceutical Holding (BHVN)
-
William Blair Reiterates Outperform Rating on Health Catalyst Inc. (HCAT)
-
William Blair Reiterates Market Perform Rating on Green Dot (GDOT)
-
William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY)
-
ITM to Participate in Upcoming Investor Conferences
-
William Blair Downgrades TTEC Holdings Inc. (TTEC) to Market Perform
-
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Novanta prices $550 million tangible equity units offering at $50 per unit
-
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
-
William Blair Downgrades Sweetgreen Inc (SG) to Market Perform
-
William Blair Downgrades DENTSPLY SIRONA (XRAY) to Market Perform
-
BillionToOne raises $273.1 million in upsized IPO
-
Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering
-
Exzeo Group closes $168 million IPO on NYSE
-
Exzeo Group, Inc. Announces Closing of Initial Public Offering
-
CarMax's longtime CEO Bill Nash to depart; shares plunge
-
ICR Announces Sponsors for the 2026 ICR Conference
-
Centrus Energy announces $1 billion at-the-market equity offering program
-
Centrus Announces "At-the-Market" Equity Offering Program
-
William Blair Downgrades CarMax (KMX) to Market Perform 'on Worsening Trends and CEO Transition'
-
William Blair on Arm Holdings (ARM): 'We continue to see Arm as a long-term winner'
-
William Blair on DoorDash Inc. (DASH): 'Another Strong Quarter Takes a Back Seat to Increased Investment Expectations'
-
William Blair on Costco (COST): 'October Sales Update; Strong Comps Could Suggest a Better-Than-Expected Holiday Against Bearish Investor Sentiment'
-
William Blair Upgrades LegalZoom.com Inc (LZ) to Outperform
-
BillionToOne prices upsized IPO at $60 per share
-
BillionToOne Announces Pricing of Upsized Initial Public Offering
-
Insurance tech firm Exzeo valued at $1.9 billion in muted NYSE debut
-
William Blair Downgrades Biohaven Pharmaceutical Holding (BHVN) to Market Perform
-
William Blair on Biohaven (BHVN): 'Expect Weakness'

